616 Krankheiten
Refine
Has Fulltext
- yes (173) (remove)
Is part of the Bibliography
- yes (173)
Year of publication
Document Type
- Journal article (173) (remove)
Language
- English (173)
Keywords
- breast cancer (6)
- Fabry disease (5)
- Parkinson’s disease (4)
- dopamine (4)
- follow-up (4)
- oxidative stress (4)
- quality of life (4)
- schizophrenia (4)
- MRI (3)
- Mice (3)
- antibodies (3)
- brain (3)
- chronic kidney disease (3)
- enzyme replacement therapy (3)
- gene (3)
- genetics (3)
- heart failure (3)
- hypertrophic cardiomyopathy (3)
- magnetic resonance imaging (3)
- mice (3)
- mortality (3)
- mouse model (3)
- prognosis (3)
- survival (3)
- ADHD (2)
- AIDS (2)
- B cells (2)
- CSF (2)
- Fabry (2)
- Fabry nephropathy (2)
- Fabry-associated pain (2)
- HIV (2)
- IL-10 (2)
- Inflammation (2)
- P300 (2)
- Pain (2)
- Parkinson disease (2)
- Parkinson's disease (2)
- Therapy (2)
- anxiety (2)
- back pain (2)
- basal ganglia (2)
- biomarker (2)
- biomarkers (2)
- cancer treatment (2)
- cardiovascular disease (2)
- cardiovascular events (2)
- cell cultures (2)
- children (2)
- coronary heart disease (2)
- deep brain stimulation (2)
- depression (2)
- disease (2)
- epidemiology (2)
- expression (2)
- family (2)
- fibrosis (2)
- fracture (2)
- gastric cancer (2)
- gene expression (2)
- genome-wide association (2)
- hearing loss (2)
- hemodialysis (2)
- hip (2)
- hospitalization (2)
- human immunodeficiency virus (2)
- impact (2)
- infection (2)
- inflammation (2)
- leukemia (2)
- lung (2)
- lung cancer (2)
- magnetic resonance (2)
- major depressive disorder (2)
- melanoma (2)
- messenger RNA (2)
- metaanalysis (2)
- multiple sclerosis (2)
- mutation (2)
- myasthenia gravis (2)
- myocardial infarction (2)
- oncolytic viruses (2)
- osteoarthritis (2)
- osteoporosis (2)
- population (2)
- predictors (2)
- prevalence (2)
- prostate cancer (2)
- protein (2)
- pulmonary embolism (2)
- randomized controlled trial (2)
- risk (2)
- risk factors (2)
- sepsis (2)
- shock (2)
- stroke (2)
- surgery (2)
- susceptibility (2)
- teriparatide (2)
- therapy (2)
- treatment (2)
- trial (2)
- update (2)
- validation (2)
- validity (2)
- ventilation (2)
- walking (2)
- 1p13.3 (1)
- 1q21 (1)
- 1st International Workshop (1)
- 2B (1)
- 5-Fluorouracil (1)
- 5IA-SPECT (1)
- 7q11.2 (1)
- A53T (1)
- ADAMTS (1)
- ALS (1)
- Acute Myocardial Infarction (1)
- Adrenocortical Carcinoma (1)
- Agalsidase beta therapy (1)
- Akutes Nierenversagen (1)
- Alpha galactosidase (1)
- Alzheimer's disease (1)
- Alzheimer’s disease (1)
- Amino acids (1)
- Anderson-Fabry Disease (1)
- Ankyrin (1)
- ApoE\(^{(-/-)}\) (1)
- Arterial water (1)
- Attention-deficit/hyperactivity disorder (1)
- B lymphocytes (1)
- B-cell lymphoma (1)
- BCI (1)
- BK virus (1)
- BRAF mutation (1)
- BRCA1 (1)
- Barrett-Ösophagus (1)
- Barthel-Index (1)
- Bessle functions (1)
- Beta-glucocerebrosidase (1)
- Biomarkers (1)
- Blood-brain barrier (1)
- Brain (1)
- Breast cancer (1)
- Breast-tumors (1)
- C-MYC (1)
- CBF (1)
- CD4 T cells (1)
- CMV (1)
- CNO (1)
- CRMO (1)
- Capicua transcriptional repressor (1)
- Cardiovascular Magnetic Resonance (1)
- Charcot–Marie–Tooth disease (1)
- Chemotherapy (1)
- Childhood (1)
- Clinical manifestations (1)
- Coefficient (1)
- Comorbidities (1)
- Comorbidity survey replication (1)
- D313Y genotype (1)
- DAT (1)
- DIRA (1)
- DNA (1)
- DNA Methylation (1)
- DRD2 (1)
- DSM-5 (1)
- DSM-IV (1)
- DSM-IV disorders (1)
- Deflazacort (1)
- Demyelinating peripheral neuropathy (1)
- Depression (1)
- Diagnosis (1)
- Disease (1)
- Disease progression (1)
- Disease-modifying therapies (1)
- Draize eye test (1)
- Drug development (1)
- Drug resistance (1)
- Duchenne dystrphy (1)
- E3 ubiquitin ligase (1)
- EAU guidelines (1)
- EBV (1)
- EDS (1)
- ELISPOT (1)
- ENV (1)
- EORTC-BN20 (1)
- EORTC-QLQ-C15-PAL (1)
- EQ-5D (1)
- EUROASPIRE survey (1)
- Early-onset (1)
- Ehlers-Danlos syndrome (1)
- Enzyme replacement therapy (1)
- Enzyme-Linked Immunospot assay (ELISPOT) (1)
- Epilepsy (1)
- Epstein-Barr-virus (1)
- Experimental stroke (1)
- Extramedullary disease (1)
- F-19 MRI (1)
- FDG (1)
- FDG-PET/CT (1)
- FDG-PET/MRI (1)
- FP-CIT SPECT (1)
- Fabry cardiomyopathy (1)
- Fabry patient (1)
- Follow-up (1)
- Fontan’s Operation (1)
- Frabin/Fgd4 (1)
- GLA protein UCMGP (1)
- GP41 cytoplasmic tail (1)
- Gene-expression (1)
- HAND (1)
- HCMV infection (1)
- HE-3 diffusion MRI (1)
- HER2 (1)
- Haemodialysis (1)
- Heart failure (1)
- Heart failure with preserved ejection fraction (1)
- Heart failure with reduced ejection fraction (1)
- Helicobacter pylori (1)
- Hepatitis C infection (1)
- Hodgkin-lymphoma (1)
- Homoarginine (1)
- Hurst Exponent (1)
- ICD-coding of CKD (1)
- IFN-γ (1)
- IL-2 (1)
- IL28B (1)
- IMpACT (1)
- Illumina Human Exome Bead Chip (1)
- Images (1)
- In-vivo (1)
- Infarct Zone (1)
- Insulin Degrading Enzyme (1)
- Iron Oxide Nanoparticle (1)
- Iron-oxide (1)
- Iron-uptake (1)
- Krebs (1)
- L-arginine (1)
- LC-ESI/MS/MS (1)
- LIMP-2 (1)
- LPHN3 (1)
- LV mass (1)
- Lesions (1)
- Lewy-like pathology (1)
- Limb girdle muscular dystrophy (LGMD) (1)
- Lipom (1)
- Lyso-Gb3 (1)
- MCPH1 (1)
- MRI reporter (1)
- MS (1)
- MTCH2 (1)
- Magnetic-resonance (1)
- Majeed (1)
- Metaanalysis (1)
- MicroRNAs (1)
- Miyoshi myopathy (1)
- Morbus Fabry (1)
- Multiple myeloma (1)
- Multiple sclerosis (1)
- Mycobacterium caprae (1)
- Mycobacterium tuberculosis complex (1)
- N-Myc down regulated gene 1 (1)
- NADPH oxidase inhibitors (1)
- NADPH oxidases (NOX) (1)
- NCAM1 (1)
- NMO-IGG (1)
- NPU (1)
- NRG1 (1)
- Neuropathy (1)
- Neuroprotection (1)
- Normal breast (1)
- OECD guideline (1)
- OncotypeDX\(^{®}\) (1)
- Outcome survey (1)
- Ovarian (1)
- P. falciparum (1)
- PAI-1 (1)
- PAPA (1)
- PDH (1)
- PET/CT (1)
- PSMA (1)
- Parkinson (1)
- Parkinsons disease (1)
- Particles (1)
- Perfusion (1)
- Pharmacological management (1)
- Physical impairment (1)
- Prevalence (1)
- Primary cell lines (1)
- Prostatakrebs (1)
- Proteins (1)
- Pycnogenol (1)
- Quality of life (1)
- RDoC (1)
- RNA interference (1)
- Randomized controlled trial (1)
- Rats (1)
- Rho-GTPase Cdc42 (1)
- Rochester diabetic neuropathy (1)
- SAH (1)
- SCD (1)
- SCF (1)
- SKP1 (1)
- SVR (1)
- Salmonella-typhimurium (1)
- Scale (1)
- Short dsRNA oligonucleotides (1)
- Small-fiber neuropathy (1)
- Soft-tissue infection (1)
- Stem cells plasticity (1)
- Strahlentherapie (1)
- Sudden cardiac death (1)
- Sugar-transport (1)
- Superparamagnetic Iron Oxide (1)
- Surrogate endpoints (1)
- T-DM1 (1)
- T-PA (1)
- T-cell reactivity (1)
- TIC disorders (1)
- TLR4 (1)
- TNF-α (1)
- Thyroid cancer (1)
- Tissue engineering (1)
- Tracking (1)
- Treatment (1)
- Trypanosoma (1)
- Tuberkulose (1)
- UME6 (1)
- United States (1)
- V. saphena magna (1)
- VAL66MET polymorphism (1)
- Virologie (1)
- Von-Willebrand-factor (1)
- WB-DW-MRI (1)
- ablation (1)
- accuracy (1)
- acetylsalicylic acid exacerbated respiratory disease (1)
- acoustic startle (1)
- acquired immunodeficiency-syndrome (1)
- activation (1)
- acute (1)
- acute ischemic stroke (1)
- acute kidney injury (1)
- acute liver failure (1)
- acute management of stroke (1)
- acute neurology (1)
- acute stroke imaging (1)
- acute stroke management (1)
- acute stroke outcome (1)
- adalimumab (1)
- adjuvant (1)
- adrenal cortex hormones (1)
- adrenal cortex neoplasms (1)
- adrenal imaging (1)
- adrenal tumours (1)
- adult (1)
- adulthood (1)
- aerobic glycolysis (1)
- agalsidase-beta (1)
- age (1)
- alendronate (1)
- alkaline phosphatase (1)
- allergic rhinitis (1)
- allografts (1)
- alpha galactosidase (1)
- alpha-galactosidase A (1)
- alpha-galactosidase-A (1)
- alpha-synuclein (1)
- alternatives (1)
- alveolar (1)
- amyotrophic lateral sclerosis (1)
- animal model (1)
- animal models (1)
- anti-aquaporin-4 antibody (1)
- antigen (1)
- antioxidant function (1)
- antirheumatic agents (1)
- aortic valve (1)
- aortic valve disease (1)
- apomorphine (1)
- apoptosis (1)
- aquaporin-4 autoantibodies (1)
- argeted therapy (1)
- arm (1)
- artery occlusion (1)
- arthritis (1)
- arthroplasty (1)
- aspirin sensitivity (1)
- aspirin-induced asthma (1)
- association (1)
- asthma (1)
- astrocytic tumor (1)
- atypical (1)
- auditory (1)
- autism (1)
- autoimmunity (1)
- autonomous cortisol secretion (1)
- awareness (1)
- axonopathic changes (1)
- axons (1)
- beta oscillations (1)
- beta-TRCP (1)
- binding (1)
- binge eating (1)
- bioinformatics (1)
- biopsy findings (1)
- biosynthesis (1)
- bipolar disorder (1)
- blood biomarker (1)
- blood brain barrier (1)
- blood-glucose control (1)
- bone (1)
- bone colonization (1)
- bone formation (1)
- bone marrow transplantation (1)
- bone-mineral density (1)
- brain cancer (1)
- brain computer interface (1)
- brain edema (1)
- brain tumours (1)
- calcium (1)
- cancer (1)
- cancer patients (1)
- carcinomas (1)
- cardiac energy metabolism (1)
- cardiac hypertrophy (1)
- cardiac magnetic resonance imaging (1)
- cardiogenic (1)
- cardiopulmonary exercise testing (1)
- cardiovascular care (1)
- cardiovascular magnetic-resonance (1)
- cardiovascular morbidity (1)
- cardiovascular risk factors (1)
- cartilage (1)
- cell cycle (1)
- cell-cycle arrest (1)
- cells (1)
- cellular proteins (1)
- central nervous system (1)
- cerebrospina (1)
- cerebrospinal fluid culture (1)
- cerebrospinal-fluid (1)
- chemical properties (1)
- chemotherapy (1)
- childhood cancer (1)
- chip analyses (1)
- chronic distress (1)
- chronic heart failure (1)
- chronic kidney-disease (1)
- chronic thromboembolic pulmonary hypertension (1)
- chronic viral infection (1)
- classification (1)
- clinical (1)
- clinical diagnosis (1)
- clinical study (1)
- clinical trials (1)
- clinical-practice (1)
- coefficient (1)
- cognitive decline (1)
- collarless (1)
- colony-stimulating factor (1)
- colorectal cancer (1)
- common SNPS (1)
- complex diseases (1)
- complex disorders (1)
- complication (1)
- comprehensive management (1)
- comprehensive psychosomatic assessment (1)
- computed tomography (1)
- consortium (1)
- contrast-enhanced MRI (1)
- controlled clinical-trials (1)
- coordination (1)
- copy number variants (1)
- cornea verticillata (1)
- corneal equivalent (1)
- coronary artery disease (1)
- coronary calcification (1)
- coronary-artery calcification (1)
- coverage (1)
- crantiectomy (1)
- craving (1)
- creatine synthesis (1)
- critically ill (1)
- cryptogenic stroke (1)
- cue (1)
- cystic fibrosis (1)
- cytokine (1)
- cytokine secretion kinetics (1)
- cytomegalovirus (1)
- damage responses (1)
- darbepoetin alpha (1)
- database (1)
- decompressive surgery (1)
- degeneration (1)
- dehydrogenases (1)
- dendritic cells (1)
- dentate gyrus (1)
- dependency (1)
- design (1)
- dexamethasone suppression test (1)
- diabetes complications (1)
- diabetes mellitus (1)
- diabetes mellitus type 2 (1)
- diabetic mouse (1)
- diabetic nephropathy (1)
- diagnosis (1)
- dialysis (1)
- differentially expressed genes (1)
- differentiation (1)
- diffusion weighted MRI (1)
- diffusion-weighted MRI (1)
- disease progression (1)
- disease-modifying therapies (1)
- disorder (1)
- dolutegravir (1)
- dopamine acetylcholine (1)
- double-blind (1)
- drug development (1)
- duchenne muscular dystrophy (1)
- duodenal levodopa infusion (1)
- dysferlinopathy (1)
- dyspnea (1)
- early diagnosis (1)
- ejection fraction (1)
- electroporation (1)
- elispot (1)
- elucidation (1)
- embolic stroke (1)
- emotional regulation (1)
- emtricitabine (1)
- encephalitis dementia (1)
- end stage renal disease (1)
- endocrinology (1)
- endogenous psychoses (1)
- endophenotype (1)
- endotheliopathy (1)
- endotoxemia (1)
- entorhinal cortex (1)
- environment (1)
- enzyme-linked immunoassays (1)
- epigastric hernia (1)
- epimutation (1)
- eukaryota (1)
- euroaspire (1)
- exacebrated respiratory-disease (1)
- exhaustion (1)
- experimental (1)
- experimental autoimmune encephalomyelitis (1)
- expression pattern (1)
- extensiv transverse myelitis (1)
- extracellular matrix (1)
- extracellular matrix remodeling (1)
- extracorporeal membrane oxygenation (1)
- eye irritation testing (1)
- fMRI (1)
- factor expression (1)
- fatty liver disease (1)
- fear of progression (1)
- feasibility (1)
- femoral revision (1)
- fetuin A (1)
- fibrosis progression (1)
- field (1)
- fluid (1)
- fluorescent-probes (1)
- focal cerebral ischemia (1)
- focal semental glomerulosclerosis (1)
- folinic acid (1)
- food addiction (1)
- fosfomycin (1)
- foxes vulpes-vulpes (1)
- frontal cortex (1)
- functional imaging (1)
- functional neuroanatomy (1)
- gadofluorine (1)
- gadolinium-DTPA (1)
- gait (1)
- gait analysis (1)
- gambling (1)
- gastroesophageal reflux (1)
- gastroesophageal reflux disease (1)
- gemcitabine (1)
- gene ontology (1)
- gene-environment interaction (1)
- genetic heterogeneity (1)
- genetic interaction (1)
- genetic modifiers (1)
- genetic renal disease (1)
- genetic risk factor (1)
- genetic variation (1)
- genome-wide association study (GWAS) (1)
- genomic damage (1)
- germinal center (1)
- giant ventral hernia (1)
- gilles (1)
- glioblastoma cell-lines (1)
- glioblastoma multiforme (1)
- glomerular-filtration-rate (1)
- glucose transporter (1)
- glycoprotein incorporation (1)
- granzyme B (1)
- green fluorescent protein (1)
- gridle muscular-dystrophy (1)
- group-B (1)
- growth (1)
- growth factor (1)
- guideline adherence (1)
- guideline implementation (1)
- guidelines (1)
- haplogroups (1)
- hcv infection (1)
- health care research (1)
- health questionnaire (1)
- health-related quality of life (1)
- heat shock protein Hsc-70 (1)
- helminths (1)
- hematopoietic (1)
- hematopoietic stem cells (1)
- hemicraniectomy (1)
- heptacellular carcinoma (1)
- hereditary motor and sensory neuropathy (1)
- heritability (1)
- herpes virus (1)
- hospital medical complications (1)
- host genetics (1)
- human (1)
- human cancer diseases (1)
- human cytomegalovirus (HCMV) (1)
- human diseases (1)
- humanized bone models (1)
- hyperpolarized HE-3 (1)
- hyponatremia (1)
- imaging mass spectrometry (1)
- immune neuromelanin (1)
- immune response (1)
- immune suppression (1)
- immune-response (1)
- immunity (1)
- immunoglobulin-G (1)
- immunohistochemistry (1)
- immunology and microbiology section (1)
- impaction bone grafting (1)
- impulse control disorders (1)
- in situ guided tissue regeneration (1)
- in vivo (1)
- incisional hernia (1)
- induced insulin-release (1)
- infants (1)
- infectious-disease diagnostics (1)
- infiltrate (1)
- inflammatory diseases (1)
- inguinal lymph node dissection (1)
- inherited metabolic disorders (1)
- inhibitor (1)
- initial experience (1)
- insulin (1)
- insulin receptor (1)
- insulin-like growth factor 1 receptor (1)
- integrase inhibitor (1)
- interval timing (1)
- intractable hiccup (1)
- invasive cysticerocsis (1)
- involvement (1)
- irinotecan (1)
- iron oxide nanoparticles (1)
- ischaemic stroke (1)
- ischemic stroke (1)
- journals (1)
- juvenile idiopathic arthritis (1)
- kidney (1)
- kidney neoplasms (1)
- kidney-disease CKD (1)
- kidneys (1)
- kinases (1)
- kinematics (1)
- kinetics (1)
- knees (1)
- laparostomy (1)
- late gadolinium enhancement (1)
- latency (1)
- left lateral wall (1)
- left ventricular mass (1)
- left-ventricular hypertrophy (1)
- lipid desaturation (1)
- lipidomics (1)
- lipoxygenase (1)
- liver resection (1)
- locally advanced disease (1)
- loci (1)
- locus coeruleus (1)
- lovastatin (1)
- lung and intrathoracic tumors (1)
- lymph nodes (1)
- lymphoma (1)
- lysosomal storage disease (1)
- mTOR-inhibitor RAD-001 (1)
- magnetic resonance spectroscopy (1)
- magnetic resonsance imaging (1)
- magnetic-resonance behavior (1)
- magnetic-resonance-spectroscopy (1)
- malaria (1)
- malignant MCA infarct (1)
- malignant lymphoma (1)
- malignant melanoma (1)
- management (1)
- maritime pine bark extract (1)
- mass spectrometry (1)
- matrix metalloproteinase (1)
- measles (1)
- mechanical energy (1)
- mechanisms (1)
- memory (1)
- memory cells (1)
- memory deficits (1)
- meningococcal disease (1)
- meningococcal polysaccharides (1)
- mesenchymal tissues (1)
- metabolism (1)
- metabolomics (1)
- metastasis (1)
- microRNAs (1)
- microRNA–target interaction (1)
- microangiopathy (1)
- microarray (1)
- microarrays (1)
- microcephalin 1 (1)
- microdeletion (1)
- migraineur (1)
- mineral metabolism (1)
- mineralocorticoid antagonist (1)
- missing heritability (1)
- mitochondria (1)
- modular (1)
- modulation (1)
- molecular genetics (1)
- molecular medicine (1)
- monozygotic twins (1)
- mood disorder (1)
- morbidity (1)
- morphogenesis (1)
- morphometry (1)
- motor function (1)
- mouse models (1)
- movements (1)
- multicenter (1)
- multigene-array (1)
- multimodal (1)
- multiple diseases (1)
- multiple myeloma (1)
- multiple system atrophy (1)
- multiple-sclerosis (1)
- murine gammaherpesvirus 68 (1)
- muscle strength (1)
- mutant p53 (1)
- myelin (1)
- myelination (1)
- myeloid (1)
- myocardial lipid content (1)
- nab-paclitaxel (1)
- national health survey (1)
- natural-history data (1)
- neoadjuvant (1)
- neoadjuvant chemotherapy (1)
- nerve fibers (1)
- nerve ultrasonography (1)
- nervous system (1)
- neural apoptosis (1)
- neural stem cells (1)
- neuregulin-1 (1)
- neuroinflammation (1)
- neuromelanin (1)
- neuron navigator 3 (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- neurotrophic factor (1)
- neurotrophic factor gene (1)
- nicotinic receptors (1)
- nictric-oxide (1)
- noradrenalin (1)
- norepinephrine (1)
- nuclear antigen (1)
- nuclear magnetic resonance (1)
- nucleus (1)
- nucleus accumbens (1)
- number (1)
- obesity (1)
- observational study (1)
- oligonucleotides (1)
- open abdomen (1)
- optical coherence tomography (1)
- oral anticancer drugs (1)
- outcomes (1)
- overdose (1)
- oxaliplatin (1)
- p53-dependent apoptosis (1)
- p53-inducible regulator (1)
- pain (1)
- pain questionnaire (1)
- pancreatic cancer (1)
- parkinson disease (1)
- particles (1)
- partitioning analysis RPA (1)
- patient (1)
- patients’ awareness (1)
- pediatric (1)
- peptide vaccination (1)
- peripheral neuropathy (1)
- persistence (1)
- persistent ADHD (1)
- perspectives (1)
- pet (1)
- pharmacotherapy (1)
- phase contrast (1)
- phenotype (1)
- phosphodiesterase (1)
- physicians’ awareness (1)
- pine bark extract (1)
- plasma membrane (1)
- plasmid construction (1)
- plasmodium falciparum (1)
- platelet dysfunction (1)
- podocyte (1)
- point-of-care echocardiography (1)
- polymorphism (1)
- polymorphisms (1)
- polyomavirus (1)
- polyphenols (1)
- porous-coated stems (1)
- postoperativ (1)
- prednisone (1)
- preserved ejection fraction (1)
- prevalent fractures (1)
- prognostic index (1)
- progression (1)
- proliferation (1)
- prostatic neoplasms (1)
- prosthesis (1)
- proteasome (1)
- protein-protein interaction network (1)
- proteinuria (1)
- proteolipid protein gene (1)
- proton (1)
- psychiatric disorders (1)
- psychopathology (1)
- pulmonary artery (1)
- pulmonary artery pressure (1)
- pulmonary circulation (1)
- pulmonary hypertension (1)
- pulse wave velocity (1)
- pulses (1)
- qPCR (1)
- quality indicators (1)
- quality of health care (1)
- quality-of-care (1)
- radiation oncology (1)
- radical cystectomy (1)
- radiotherapy (1)
- randomized controlled study (1)
- rankin scale (1)
- rare diseases (1)
- rat (1)
- rat kidney (1)
- recurrence (1)
- recurrent Tako-Tsubo cardiomyopathy (1)
- reflex (1)
- regenerative medicine (1)
- regional recurrence (1)
- registries (1)
- registry (1)
- regression analysis (1)
- regulator (1)
- regulatory T cell (1)
- reliability (1)
- renal cancer (1)
- renal fibrosis (1)
- renal function (1)
- renal osteodystrophy (1)
- replacement (1)
- replacement therapy (1)
- respiratory virus (1)
- response evaluation (1)
- responsiveness (1)
- resting tremor (1)
- restoration (1)
- resveratrol (1)
- retinal ganglion cells (1)
- retinocochleocerebral (1)
- retrospective study (1)
- revision (1)
- rheumatoid (1)
- right inferior frontalgyrus (1)
- risk factor (1)
- risk-factors (1)
- roentgenographic assessment (1)
- rolipram (1)
- salvage radiotherapy (1)
- scaffolds (1)
- scale (1)
- sclerostin (1)
- screening for distress (1)
- search filter (1)
- secondary brain damage (1)
- secondary cancer (1)
- secondary lung tumors (1)
- self-diffusion (1)
- senescence (1)
- septal hypertrophy (1)
- septic (1)
- sequence imaging protocol (1)
- sequence variations (1)
- serogroup-Y (1)
- serotonin (1)
- serum (1)
- serum creatinine (1)
- severity (1)
- signature (1)
- single-nucleotide polymorphisms (1)
- small interfering RNAs (1)
- somatic mosaicism (1)
- spectrum disorders (1)
- spinal cord (1)
- spinal-cord (1)
- sporadic Parkinson's disease (1)
- stage renal-disease (1)
- staib agar (1)
- standardization (1)
- stem cells (1)
- steroids (1)
- streptozotocin (1)
- stroke register (1)
- stroke therapy (1)
- stroke unit (1)
- stroke unit care (1)
- structural determination (1)
- substance dependence (1)
- substance use disorder (1)
- substantia nigra (1)
- subthalamic nucleus (1)
- sudden cardiac death (1)
- suicide attempt (1)
- superficial peroneal nerve (1)
- sural nerve (1)
- surrogate endpoints (1)
- surveillance (1)
- survival analysis (1)
- survivin (1)
- sustained fear (1)
- symptoms (1)
- synovial fluid (1)
- synovitis (1)
- synthetic mesh (1)
- systolic dysfunction (1)
- tapered stem (1)
- targeted (1)
- task force (1)
- tenofovir disaproxil fumarate (1)
- term mortality (1)
- territory infaction (1)
- testicular neoplasms (1)
- therapeutic strategy (1)
- thymic carcinoma (1)
- thymoma (1)
- thymus (1)
- tinnitus (1)
- tissue engineering (1)
- transcranial direct current stimulation (1)
- transfection (1)
- transforming growth factor-beta 1 (1)
- translational stroke research (1)
- transplantation (1)
- transverse relaxation (1)
- treatment outcome (1)
- treatment response (1)
- treg cells (1)
- tremor (1)
- tuberculous meningitis (1)
- tumor (1)
- tumor stem cells (1)
- tumor-draining lymph node (1)
- tumorigenesis (1)
- twin study (1)
- type-1 matrix (1)
- uPA (1)
- ubiquitin (1)
- umbilical hernia (1)
- univentricular heart (1)
- urinary bladder neoplasms (1)
- urinary protein excretion (1)
- urine (1)
- vaccination (1)
- vaccines (1)
- vaccinia virus (1)
- vacuum conditioning (1)
- variants (1)
- varicella (1)
- vascular calcification (1)
- vascular type (1)
- vasculitis (1)
- vasculopathy (1)
- velocity (1)
- ventral hernia (1)
- ventricular tachycardia (1)
- vertebral fractures (1)
- viral replication (1)
- virions (1)
- virulence (1)
- visual (1)
- vitamin D (1)
- volume determination (1)
- whole body MRI (1)
- whole-body (1)
- whole-brain radiotherapy (1)
- α-galactosidase A (1)
- α-synuclein (1)
- β1 integrin (1)
Institute
- Medizinische Klinik und Poliklinik I (29)
- Neurologische Klinik und Poliklinik (26)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (19)
- Institut für Klinische Epidemiologie und Biometrie (10)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (10)
- Medizinische Klinik und Poliklinik II (10)
- Pathologisches Institut (10)
- Theodor-Boveri-Institut für Biowissenschaften (9)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (8)
- Klinik und Poliklinik für Nuklearmedizin (8)
Sonstige beteiligte Institutionen
Background
Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term complication following an acute pulmonary embolism (PE). It is frequently diagnosed at advanced stages which is concerning as delayed treatment has important implications for favourable clinical outcome. Performing a follow-up examination of patients diagnosed with acute PE regardless of persisting symptoms and using all available technical procedures would be both cost-intensive and possibly ineffective. Focusing diagnostic procedures therefore on only symptomatic patients may be a practical approach for detecting relevant CTEPH.
This study aimed to evaluate if a follow-up program for patients with acute PE based on telephone monitoring of symptoms and further examination of only symptomatic patients could detect CTEPH. In addition, we investigated the role of cardiopulmonary exercise testing (CPET) as a diagnostic tool.
Methods
In a prospective cohort study all consecutive patients with newly diagnosed PE (n=170, 76 males, 94 females within 26 months) were recruited according to the inclusion and exclusion criteria. Patients were contacted via telephone and asked to answer standardized questions relating to symptoms. At the time of the final analysis 130 patients had been contacted. Symptomatic patients underwent a structured evaluation with echocardiography, CPET and complete work-up for CTEPH.
Results
37.7%, 25.5% and 29.3% of the patients reported symptoms after three, six, and twelve months respectively. Subsequent clinical evaluation of these symptomatic patients saw 20.4%, 11.5% and 18.8% of patients at the respective three, six and twelve months time points having an echocardiography suggesting pulmonary hypertension (PH). CTEPH with pathological imaging and a mean pulmonary artery pressure (mPAP) ≥ 25 mm Hg at rest was confirmed in eight subjects. Three subjects with mismatch perfusion defects showed an exercise induced increase of PAP without increasing pulmonary artery occlusion pressure (PAOP). Two subjects with pulmonary hypertension at rest and one with an exercise induced increase of mPAP with normal PAOP showed perfusion defects without echocardiographic signs of PH but a suspicious CPET.
Conclusion
A follow-up program based on telephone monitoring of symptoms and further structured evaluation of symptomatic subjects can detect patients with CTEPH. CPET may serve as a complementary diagnostic tool.
The idea that specific kind of foods may have an addiction potential and that some forms of overeating may represent an addicted behavior has been discussed for decades. In recent years, the interest in food addiction is growing and research on this topic lead to more precise definitions and assessment methods. For example, the Yale Food Addiction Scale has been developed for the measurement of addiction-like eating behavior based on the diagnostic criteria for substance dependence of the fourth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). In 2013, diagnostic criteria for substance abuse and-dependence were merged, thereby increasing the number of symptoms for substance use disorders (SUDs) in the DSM-5. Moreover, gambling disorder is now included along SUDs as a behavioral addiction. Although a plethora of review articles exist that discuss the applicability of the DSM-IV substance dependence criteria to eating behavior, the transferability of the newly added criteria to eating is unknown. Thus, the current article discusses if and how these new criteria may be translated to overeating. Furthermore, it is examined if the new SUD criteria will impact future research on food addiction, for example, if "diagnosing" food addiction should also be adapted by considering all of the new symptoms. Given the critical response to the revisions in DSM-5, we also discuss if the recent approach of Research Domain Criteria can be helpful in evaluating the concept of food addiction.
Background: Depression and anxiety are common and independent outcome predictors in patients with chronic heart failure (CHF). However, it is unclear whether CHF causes depression. Thus, we investigated whether mice develop anxiety- and depression-like behavior after induction of ischemic CHF by myocardial infarction (MI).
Methods and Results: In order to assess depression-like behavior, anhedonia was investigated by repeatedly testing sucrose preference for 8 weeks after coronary artery ligation or sham operation. Mice with large MI and increased left ventricular dimensions on echocardiography (termed CHF mice) showed reduced preference for sucrose, indicating depression-like behavior. 6 weeks after MI, mice were tested for exploratory activity, anxiety-like behavior and cognitive function using the elevated plus maze (EPM), light-dark box (LDB), open field (OF), and object recognition (OR) tests. In the EPM and OF, CHF mice exhibited diminished exploratory behavior and motivation despite similar movement capability. In the OR, CHF mice had reduced preference for novelty and impaired short-term memory. On histology, CHF mice had unaltered overall cerebral morphology. However, analysis of gene expression by RNA-sequencing in prefrontal cortical, hippocampal, and left ventricular tissue revealed changes in genes related to inflammation and cofactors of neuronal signal transduction in CHF mice, with Nr4a1 being dysregulated both in prefrontal cortex and myocardium after MI.
Conclusions: After induction of ischemic CHF, mice exhibited anhedonic behavior, decreased exploratory activity and interest in novelty, and cognitive impairment. Thus, ischemic CHF leads to distinct behavioral changes in mice analogous to symptoms observed in humans with CHF and comorbid depression.